Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnosis of CIDP.

Norman Latov1

  • 1Peripheral Neuropathy Center, Weill Medical College of Cornell University, New York, NY 10022, USA.

Neurology
|December 25, 2002
PubMed
Summary

Diagnosing chronic inflammatory demyelinating polyneuropathy (CIDP) is challenging due to its varied symptoms and diagnostic limitations. Early treatment is crucial for patients with suspected CIDP, with response to therapy confirming the diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time course of the autoantibody response to therapy in anti-MAG neuropathy: TWO case REPORTS.

Heliyon·2024
Same author

Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials.

Arquivos de neuro-psiquiatria·2024
Same author

Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial.

Journal of the peripheral nervous system : JPNS·2023
Same author

Correction: Latov, N. <i>Campylobacter jejuni</i> Infection, Anti-Ganglioside Antibodies, and Neuropathy. <i>Microorganisms</i> 2022, <i>10</i>, 2139.

Microorganisms·2023
Same author

Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations.

Expert review of neurotherapeutics·2023
Same author

<i>Campylobacter jejuni</i> Infection, Anti-Ganglioside Antibodies, and Neuropathy.

Microorganisms·2022

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disorder affecting peripheral nerve myelin.
  • Clinical diagnosis of CIDP is complicated by disease heterogeneity, multifocal presentation, and limitations in diagnostic techniques.
  • Current research criteria for CIDP are too stringent for routine clinical practice, leading to underdiagnosis and delayed treatment.

Purpose of the Study:

  • To highlight the diagnostic challenges of CIDP in clinical practice.
  • To propose a practical approach for diagnosing CIDP in patients with unexplained neuropathy.
  • To emphasize the importance of therapeutic trials in confirming CIDP diagnosis.

Main Methods:

  • Review of clinical presentation and pathophysiology of CIDP.
  • Analysis of electrophysiologic findings (nerve conduction velocities, F-waves, conduction block, temporal dispersion).
  • Evaluation of response to therapeutic interventions.

Main Results:

  • CIDP is often underdiagnosed due to lack of standardized clinical diagnostic criteria.
  • Patients with unexplained neuropathy and specific electrophysiologic abnormalities are likely to have CIDP.
  • A positive response to therapy serves as a key diagnostic confirmation.

Conclusions:

  • There is a need for agreed-upon clinical diagnostic criteria for CIDP.
  • Suspected CIDP cases warrant empirical treatment if specific electrophysiologic criteria are met.
  • Therapeutic response is a critical factor in confirming the diagnosis of CIDP.

Related Experiment Videos